Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KYNTRA BIO, INC.
Report date September 07, 2021 · Filed September 10, 2021
Section 16 reporting ended · disclosed 2021-09-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 274,536 |
Reported balance
After 2021-09-07 transaction · row 1
1 source rowRow 1 · 2021-09-07 · Tax withholding · Disposed 2,141 · Balance 274,536 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2019 Filed Mar 7, 2019 00:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 5,242 | $55.58 | $291,350.36 |
DisclosureSEC source: 0001209191-19-017533 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,169 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 04, 2019 Filed Mar 7, 2019 00:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 693 | $58.69 | $40,672.17 |
DisclosureSEC source: 0001209191-19-017533 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,411 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,787 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-19-015160 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,255 Underlying: Common Stock · 14,787 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 14,787 | $60.08 | $888,391.13 |
DisclosureSEC source: 0001209191-19-015160 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,104 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $60.00 to $60.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 23:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 14,787 | $29.66 | $438,582.42 |
DisclosureSEC source: 0001209191-19-015160 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 8, 2019 00:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 51,800 | $0.00 Strike: $57.33 | $0.00 |
DisclosureSEC source: 0001209191-19-008267 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,800 Underlying: Common Stock · 51,800 shares Expires 2029-02-05 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2020, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 05, 2019 Filed Feb 8, 2019 00:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 31,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008267 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,104 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2020, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 18, 2018 Filed Dec 21, 2018 01:34 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,330 | $41.10 | $136,863.00 |
DisclosureSEC source: 0001209191-18-063782 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,004 F1 · kind: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 01:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,277 | $40.93 | $93,197.61 |
DisclosureSEC source: 0001209191-18-061410 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,334 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 03, 2018 Filed Dec 7, 2018 01:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 993 | $43.93 | $43,622.49 |
DisclosureSEC source: 0001209191-18-061410 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,611 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 21:19 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,318 | $59.50 | $137,921.00 |
DisclosureSEC source: 0001209191-18-051119 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,604 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 12, 2018 Filed Sep 14, 2018 21:19 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,500 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-18-051119 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,500 Underlying: Common Stock · 10,500 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 12, 2018 Filed Sep 14, 2018 21:19 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 10,500 | $2.90 | $30,450.00 |
DisclosureSEC source: 0001209191-18-051119 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 20:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,011 | $57.35 | $57,980.85 |
DisclosureSEC source: 0001209191-18-050653 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,422 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 00:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,277 | $57.30 | $130,472.10 |
DisclosureSEC source: 0001209191-18-049976 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,433 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 994 | $61.05 | $60,683.70 |
DisclosureSEC source: 0001209191-18-049976 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,710 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 20:46 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,750 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-18-038098 · doc4.xml · derivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,250 Underlying: Common Stock · 7,750 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 20:46 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 7,750 | $60.00 | $465,000.00 |
DisclosureSEC source: 0001209191-18-038098 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,704 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 20:46 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 7,750 | $25.40 | $196,850.00 |
DisclosureSEC source: 0001209191-18-038098 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 20:46 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,319 | $57.70 | $133,806.30 |
DisclosureSEC source: 0001209191-18-038098 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,704 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 08, 2018 Filed Jun 8, 2018 23:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,011 | $55.55 | $56,161.05 |
DisclosureSEC source: 0001209191-18-036788 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,023 F2 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 23:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,277 | $56.60 | $128,878.20 |
DisclosureSEC source: 0001209191-18-036788 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,034 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 04, 2018 Filed Jun 5, 2018 23:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,013 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-18-035943 · doc4.xml · derivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 6,013 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| June 04, 2018 Filed Jun 5, 2018 23:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 6,013 | $55.16 | $331,677.08 |
DisclosureSEC source: 0001209191-18-035943 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,311 F2 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $55.00 to $55.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2018 Filed Jun 5, 2018 23:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 6,013 | $19.39 | $116,592.07 |
DisclosureSEC source: 0001209191-18-035943 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 23:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 993 | $54.05 | $53,671.65 |
DisclosureSEC source: 0001209191-18-035943 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,311 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| May 21, 2018 Filed May 23, 2018 23:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-18-032768 · doc4.xml · derivative · entry 5 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Common Stock · 7,000 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| May 21, 2018 Filed May 23, 2018 23:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,987 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-18-032768 · doc4.xml · derivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,013 Underlying: Common Stock · 7,987 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| May 21, 2018 Filed May 23, 2018 23:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 14,987 | $55.04 | $824,884.48 |
DisclosureSEC source: 0001209191-18-032768 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,304 F2 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $55.00 to $55.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 1,420 shares purchased through the Issuer's ESPP on May 15, 2018. Read SEC document |
| May 21, 2018 Filed May 23, 2018 23:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 7,000 | $25.40 | $177,800.00 |
DisclosureSEC source: 0001209191-18-032768 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,420 shares purchased through the Issuer's ESPP on May 15, 2018. Read SEC document |
| May 21, 2018 Filed May 23, 2018 23:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 7,987 | $19.39 | $154,867.93 |
DisclosureSEC source: 0001209191-18-032768 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,420 shares purchased through the Issuer's ESPP on May 15, 2018. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 22:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-18-026136 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,000 shares Expires 2020-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 22:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,550 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-18-026136 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,550 shares Expires 2020-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 22:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 33,550 | $2.90 | $97,295.00 |
DisclosureSEC source: 0001209191-18-026136 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · derivative · entry 9 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Underlying: Common Stock · 14,000 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,094 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · derivative · entry 8 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,042 Underlying: Common Stock · 22,094 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 13,804 | $53.08 | $732,716.32 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · nonDerivative · entry 6 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,334 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $52.70 to $53.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 22,290 | $52.23 | $1,164,206.70 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · nonDerivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,138 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $51.70 to $52.675. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 22,094 | $29.66 | $655,308.04 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 14,000 | $19.39 | $271,460.00 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2028-03-14 F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 13, 2018 Filed Mar 16, 2018 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,932 | $54.61 | $323,946.52 |
DisclosureSEC source: 0001209191-18-020023 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,334 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $54.15 to $55.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 01:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 79 | $54.47 | $4,303.13 |
DisclosureSEC source: 0001209191-18-018361 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,266 F2 · shares: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $54.10 to $54.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 01:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 909 | $53.45 | $48,586.05 |
DisclosureSEC source: 0001209191-18-018361 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,345 F2 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $53.10 to $53.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 01:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 906 | $52.68 | $47,728.08 |
DisclosureSEC source: 0001209191-18-018361 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,254 F2 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $52.10 to $53.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2018 Filed Mar 9, 2018 01:40 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 5,832 | $53.55 | $312,303.60 |
DisclosureSEC source: 0001209191-18-018361 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,160 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 23:46 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,860 | $54.95 | $102,207.00 |
DisclosureSEC source: 0001209191-18-016881 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,992 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 16, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,960 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · derivative · entry 12 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,960 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 16, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 560 | $56.76 | $31,785.60 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 9 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,852 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F7 · price: The shares were sold at prices ranging from $56.65 to $57.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,400 | $56.20 | $191,080.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 8 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,412 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $55.60 to $56.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.